HHS LogoU.S. Department of Health & Human ServicesNIH LogoNational Institutes of Health

Disease Information

Summary

Erdheim-Chester disease is a rare type of slow-growing blood cancer called a histiocytic neoplasm, which results in overproduction of cells called histiocytes. Histiocytes normally function to destroy foreign substances and protect the body from infection. In Erdheim-Chester disease, the excess production of histiocytes (histiocytosis) leads to inflammation that can damage organs and tissues throughout the body, causing them to become thickened, dense, and scarred (fibrotic); this tissue damage may lead to organ failure. People with Erdheim-Chester disease often have bone pain, especially in the lower legs and upper arms, due to an abnormal increase in bone density (osteosclerosis). Damage to the pituitary gland (a structure at the base of the brain that produces several hormones, including a hormone that controls the amount of water released in the urine) may result in hormonal problems such as a condition called diabetes insipidus that leads to excessive urination. Abnormally high pressure of the cerebrospinal fluid within the skull (intracranial hypertension) caused by accumulation of histiocytes in the brain may result in headaches, seizures, cognitive impairment, or problems with movement or sensation. People with this condition can also have shortness of breath, heart or kidney disease, protruding eyes (exophthalmos), skin growths, or inability to conceive a child (infertility). Affected individuals may also experience fever, night sweats, fatigue, weakness, and weight loss. The signs and symptoms of Erdheim-Chester disease usually appear between the ages of 40 and 60, although the disorder can occur at any age. The severity of the condition varies widely; some affected individuals have few or no associated health problems, while others have severe complications that can be life-threatening.

About Erdheim-Chester disease

Many rare diseases have limited information. Currently, GARD aims to provide the following information for this disease:

  • Symptoms:May start to appear as an Adult.
  • Cause:GARD does not currently have information about the cause of this disease.
  • Organizations:Patient organizations dedicated to this rare disease are available on GARD, or you may contact a GARD Information Specialist for additional information.
  • Categories:Skin diseases(Skin diseases, or integumentary system diseases, affect the skin, hair, nails, sweat glands, or oil glands.)

Resource(s) for Medical Professionals and Scientists on This Disease:

  • MONDO provides GARD with information for this disease.
  • Orphanet provides GARD with information for this disease.

Resource(s) for Medical Professionals and Scientists on This Disease:

  • MONDO provides GARD with information for this disease.
  • Orphanet provides GARD with information for this disease.

About Erdheim-Chester disease

Many rare diseases have limited information. Currently, GARD aims to provide the following information for this disease:

  • Symptoms:May start to appear as an Adult.
  • Cause:GARD does not currently have information about the cause of this disease.
  • Organizations:Patient organizations dedicated to this rare disease are available on GARD, or you may contact a GARD Information Specialist for additional information.
  • Categories:Skin diseases(Skin diseases, or integumentary system diseases, affect the skin, hair, nails, sweat glands, or oil glands.)

When Do Symptoms of Erdheim-Chester disease Begin?

Symptoms of this disease may start to appear as an Adult.

The age symptoms may begin to appear differs between diseases. Symptoms may begin in a single age range, or during several age ranges. The symptoms of some diseases may begin at any age. Knowing when symptoms may have appeared can help medical providers find the correct diagnosis.
  1. Prenatal
    Before Birth
  2. Newborn
    Birth-4 weeks
  3. Infant
    1-23 months
  4. Child
    2-11 years
  5. Adolescent
    12-18 years
  6. Adult Selected
    19-65 years
  7. Older Adult
    65+ years
Symptoms may start to appear as an Adult.
This information comes from Orphanet

Symptoms

You may have one or more symptoms, and they may be mild or severe. Having some or all of these symptoms does not mean you have this disease. Only a health care provider can diagnose you.

Common

Many people have these, but not everyone.

  • Abdominal pain
  • Abnormal aortic valve morphology
  • Abnormal shape of end part of bone (Abnormal epiphysis morphology)
  • Abnormality of the wide portion of a long bone (Abnormal metaphysis morphology)
  • Bone infection (Osteomyelitis)
  • Bone pain
  • Breakdown of bone (Osteolysis)
  • Bulging eye (Proptosis)
  • Diabetes insipidus
  • Excessive sweating (Hyperhidrosis)
  • Extreme thirst (Polydipsia)
  • Fatigue
  • Fatty deposits in skin around the eyes (Xanthelasma)
  • Fever
  • Hydronephrosis
  • Hypogonadotropic hypogonadism
  • Increased bone mineral density
  • Joint swelling
  • Painful or difficult urination (Dysuria)
  • Retroperitoneal fibrosis
  • Weight loss

Uncommon

Some people have these, but most people do not.

  • Abnormal pericardium morphology
  • Abnormality in area between air sacs in lung (Abnormal pulmonary interstitial morphology)
  • Abnormality of immune system physiology
  • Abnormality of the cerebellum (Abnormal cerebellum morphology)
  • Ataxia
  • Breathing difficulty (Dyspnea)
  • Cardiac failure (Congestive heart failure)
  • Cough
  • Death of bone due to decreased blood supply (Avascular necrosis)
  • Difficulty articulating speech (Dysarthria)
  • Drooping upper eyelid (Ptosis)
  • Fluid around lungs (Pleural effusion)
  • Increased reflexes (Hyperreflexia)
  • Involuntary, rapid, rhythmic eye movements (Nystagmus)
  • Low number of red blood cells or hemoglobin (Anemia)
  • Nausea and vomiting
  • Pulmonary scarring (Pulmonary fibrosis)
  • Renal failure (Renal insufficiency)
  • Skin rash
  • Visual impairment
This information comes from the Human Phenotype Ontology (HPO)

Navigating Health Care Decisions

On average, it can take more than six years to receive an accurate diagnosis. Many primary care providers (PCPs) may not be familiar with rare diseases, and patients often need to visit multiple specialists or seek second opinions to get answers.

If a diagnosis remains unclear, visiting a multidisciplinary care center or university hospital may help. These centers bring together teams of specialists who can work together to evaluate symptoms and coordinate a diagnosis. This team-based approach is also helpful after a diagnosis, when managing care for rare diseases.

Because only about 5% of rare diseases have FDA-approved treatments, finding the right healthcare team to manage your symptoms and overall health is essential. People living with rare diseases often face challenges such as delayed diagnosis, limited treatment options, and difficulty accessing knowledgeable providers. Building a care team that understands your needs can make a significant difference in your quality of life.

Your Health Care Team

Why is building the right health care team important?

Building the right health care team is key to the diagnosis, treatment, and management of your long-term health journey living with a rare disease. Start by choosing a primary care provider (PCP). Your PCP will be your main point of contact and help coordinate care with other medical professionals. Your PCP may order tests or refer you to specialists. To find a PCP near you, use the Medicare provider search tool and enter your location and “Primary Care Provider.”

Seeing multiple specialists is important for people with rare diseases because these conditions often affect many parts of the body and require care from doctors with different expertise. Most primary care providers may not be familiar with rare diseases, so involving specialists can lead to a more accurate diagnosis and better care. A coordinated team approach ensures that all symptoms are addressed and that care is well-managed. It can also connect patients with the latest research or treatment options.

These specialists may help in the diagnosis, management, and treatment of Erdheim-Chester disease:

Rheumatologists are doctors with specialized training in diagnosing and managing diseases caused by inflammation when the body’s immune system does not work properly. This includes autoimmune diseases such as rheumatoid arthritis, lupus, and vasculitis, as well as autoinflammatory conditions. They may use lab tests, imaging, or biopsies to identify the cause and monitor disease activity.

You may want to consider bringing a copy of your medical history and a list of any medications to your appointment.

Ask your primary care provider for a referral or use this directory provided by the American College of Rheumatology to find a specialist.
Dermatologists are doctors trained to diagnose and treat conditions that affect the skin, hair, and nails. Because the skin can show signs of many health issues, dermatologists often gain important insights by examining it. They commonly treat skin infections, rashes, eczema, hair loss, and skin cancers. To diagnose some conditions, dermatologists may take small skin samples (biopsies) for testing. Treatments can include medications, light therapies such as ultraviolet radiation, and surgery to remove damaged tissue or skin cancers.

You may want to consider bringing a copy of your medical history and a list of any medications to your appointment.

Ask your primary care provider for a referral or use this directory provided by the American Academy of Dermatology Association to find a specialist.

Multidisciplinary Care Centers

Is It Time to Get a Second Opinion or Specialized Evaluation?

If you've visited your PCP, met with specialists, and undergone the recommended tests, but are still searching for a diagnosis, it may be time to visit an academic medical center or, for pediatric patients, a children's hospital. Academic medical centers and children's hospitals, often called multidisciplinary care centers, typically bring together specialists from different fields to work together on complex cases like rare diseases.

Multidisciplinary care centers may offer more coordinated care and be involved in clinical research, which may help reduce the time to diagnosis and provide access to emerging diagnostic tools. Specialists at these centers may have a deeper understanding of rare diseases and serve as a resource when you'd like a second opinion, particularly when test results or treatment plans are not delivering expected results.

Find hospitals that may partner with medical schools and programs in your area. 

Rare Disease Experts

How can you find a rare disease expert?

If a diagnosis, care management, or treatment plan remains unclear despite extensive efforts by your PCP and specialists, it may be time to find a rare disease expert for your disease, if available. A rare disease expert is a medical provider that has knowledge or training on specific rare disease(s), but there may only be a few experts in your state, region, or country. Rare disease experts may work at large research or teaching hospitals, sometimes called centers of excellence. Centers of Excellence commit to sharing knowledge and best practices that can lead to improved care and treatment for individuals living with a rare disease. 

You can also contact a GARD Information Specialist for help finding experts, centers of excellence, or clinics that focus on your disease.
You can ask your care providers for help finding an expert or use directory tools to search for experts near you. The following organization(s) may maintain a list of experts or expert centers for people living with Erdheim-Chester disease:

Find Your Community

How can patient organizations help?

Patient organizations can help patients and families connect. They build public awareness of the disease and are a driving force behind research to improve patients' lives. They may offer online and in-person resources to help people live well with their disease. Many collaborate with medical experts and researchers.

Services of patient organizations differ, but may include:

  • Ways to connect to others and share personal stories
  • Easy-to-read information
  • Up-to-date treatment and research information
  • Patient registries
  • Lists of specialists or specialty centers
  • Financial aid and travel resources


Please note: GARD provides organizations for informational purposes only and not as an endorsement of their services. Contact a GARD Information Specialist for more information on organizations that may be dedicated to this disease. Please contact an organization directly if you have questions about the information or resources it provides.


View GARD's criteria for including patient organizations, which can be found under the FAQs on our About GARD page. Request an update or to have your organization added to GARD. 

Patient Organizations

3 Organizations

ECD Global Alliance

People With

Erdheim-Chester disease

Helpful Links
Country

United States

Histiocytosis Association

People With

Erdheim-Chester disease

Helpful Links
Country

United States

Children's Skin Disease Foundation

People With

Skin diseases

Country

United States

OrganizationPeople WithHelpful LinksCountry
ECD Global AllianceErdheim-Chester diseaseList of Experts
Research Registry		United States
Histiocytosis AssociationErdheim-Chester diseaseList of Experts
Research Registry		United States
Children's Skin Disease FoundationSkin diseasesUnited States

Participate in Research

Clinical studies are a part of clinical research and play an important role in medical advances for rare diseases. Through clinical studies, researchers may ultimately uncover better ways to treat, prevent, diagnose, and understand human diseases.

What Are Clinical Studies?

Clinical studies are medical research involving people as participants. There are two main types of clinical studies:

  1. Clinical trials determine if a new test or treatment for a disease is effective and safe by comparing groups receiving different tests/treatments.
  2. Observational studies involve recording changes over time among a specific group of people in their natural settings.

Learn more about clinical trials from this National Institutes of Health webpage.

Why Participate in Clinical Studies?

People participate in clinical trials for many reasons. People with a disease may participate to receive the newest possible treatment and additional care from clinical study staff as well as to help others living with the same or a similar disease. Healthy volunteers may participate to help others and to contribute to moving science forward.

To find the right clinical study we recommend you consult your doctors, other trusted medical professionals, and patient organizations. Additionally, you can use ClinicalTrials.gov to search for clinical studies by disease, terms, or location.

What if There Are No Available Clinical Studies?

ResearchMatch helps connect people interested in research studies  with researchers from top medical centers across the United States. Anyone from the U.S. can register with this free program funded by NIH. Researchers from participating institutions use the database to search for and invite patients or healthy volunteers who meet their study criteria to participate.

Why may you want to consider joining the All of Us Research Program?

The All of Us Research Program is inviting 1 million people from all backgrounds across the U.S. to help build one of the most diverse health databases in history. Researchers will use the data to learn how our biology, lifestyle, and environment affect health. This may one day help them find ways to treat and prevent diseases.

ClinicalTrials.gov, an affiliate of NIH, provides current information on clinical research studies in the United States and abroad. Talk to a trusted doctor before choosing to participate in any clinical study. We recommend checking this site often and searching for studies with related terms/synonyms to improve results.
Search ClinicalTrials.gov for this disease.
GARDGenetic and Rare Diseases
Information Center
Contact a GARD Information Specialist if you need help finding more information on this rare disease or available clinical studies. Please note that GARD cannot enroll individuals in clinical studies.
Contact GARD
Please allow 2 to 10 business days for us to respond.

Sources & References

Last Updated: September 2026